Noonan Syndrome
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
Contribution of RIT1 mutations to the pathogenesis of Noonan syndrome: four new cases and further evidence of heterogeneity.
|
24939608 |
2014 |
Noonan Syndrome
|
0.900 |
Biomarker
|
disease |
CLINGEN |
Because of the relatively high frequency of mutations in RIT1 among patients with NS and its occurrence in different populations, we suggest that it should be added to the list of genes included in panels for the molecular diagnosis of NS through targeted next-generation sequencing.
|
25124994 |
2014 |
Noonan Syndrome
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
Oncogenic RIT1 mutations in lung adenocarcinoma.
|
24469055 |
2014 |
Noonan Syndrome
|
0.900 |
GeneticVariation
|
disease |
CLINVAR |
Expression of the mutant RASA2, MAP2K1, or RIT1 alleles in heterologous cells increased RAS-ERK pathway activation, supporting a causative role in NS pathogenesis.
|
25049390 |
2014 |
Noonan Syndrome
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Because of the relatively high frequency of mutations in RIT1 among patients with NS and its occurrence in different populations, we suggest that it should be added to the list of genes included in panels for the molecular diagnosis of NS through targeted next-generation sequencing.
|
25124994 |
2014 |
Noonan Syndrome
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
Expression of the mutant RASA2, MAP2K1, or RIT1 alleles in heterologous cells increased RAS-ERK pathway activation, supporting a causative role in NS pathogenesis.
|
25049390 |
2014 |
Noonan Syndrome
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations.
|
24803665 |
2014 |
Noonan Syndrome
|
0.900 |
GeneticVariation
|
disease |
CLINVAR |
Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations.
|
24803665 |
2014 |
Noonan Syndrome
|
0.900 |
Biomarker
|
disease |
CLINGEN |
Expression of the mutant RASA2, MAP2K1, or RIT1 alleles in heterologous cells increased RAS-ERK pathway activation, supporting a causative role in NS pathogenesis.
|
25049390 |
2014 |
Noonan Syndrome
|
0.900 |
GermlineCausalMutation
|
disease |
ORPHANET |
These results demonstrate that gain-of-function mutations in RIT1 cause Noonan syndrome and show a similar biological effect to mutations in other RASopathy-related genes.
|
23791108 |
2013 |
Noonan Syndrome
|
0.900 |
GeneticVariation
|
disease |
BEFREE |
These results demonstrate that gain-of-function mutations in RIT1 cause Noonan syndrome and show a similar biological effect to mutations in other RASopathy-related genes.
|
23791108 |
2013 |
Noonan Syndrome
|
0.900 |
Biomarker
|
disease |
CLINGEN |
The RASopathies.
|
23875798 |
2013 |
Noonan Syndrome
|
0.900 |
Biomarker
|
disease |
CLINGEN |
These results demonstrate that gain-of-function mutations in RIT1 cause Noonan syndrome and show a similar biological effect to mutations in other RASopathy-related genes.
|
23791108 |
2013 |
Noonan Syndrome
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
These results demonstrate that gain-of-function mutations in RIT1 cause Noonan syndrome and show a similar biological effect to mutations in other RASopathy-related genes.
|
23791108 |
2013 |